ZURICH, March 16 /PRNewswire/ --

- BT inmo Chooses Qnective Inc

Qnective Inc., a U.S. public company, headquartered in Zurich, Switzerland, can post one of its first significant triumphs. BT inmo, a wholly owned subsidiary of BT Telecommunications Plc, has purchased a licence for global sales of mobile VoIP solutions from Qnective.

The Qtalk product family forms the basis for secure, cost-optimised mobile services which BT inmo is developing for BT Global Services.

Qnective is specialised in the development of VoIP (Voice over IP) voice and data solutions for mobile communication. The Qnective solutions are specially designed for operators and business clients.

Licensing agreement with BT inmo

MILAN, March 16 /PRNewswire/ -- Mirial, an Italian provider of products and solutions for audio/video communication over convergent networks, today announced the appointment of Brice Drogosch as Vice President Sales, America.

Being a veteran in the visual communication industry, Drogosch brings a strong expertise in the company's market to his new role, along with global sales and marketing skills developed in former positions.

In Mirial he will be managing sales for the company's line of video conferencing and visual communication products within North and South America, reporting directly to the company's CEO.

LONDON, March 16 /PRNewswire/ -- Teacher understanding of Apprenticeships must radically improve for the Government programme to achieve its full potential, according to new research by independent education foundation, Edge.

Coming ahead of the report of the Skills Commission's six-month inquiry into Apprenticeships, Edge's findings reveal that more than half (56 per cent) of the teachers surveyed rate their knowledge of Apprenticeships as poor - a real concern given young people rely on teachers for informed and impartial careers advice. By contrast, only one in twelve of teachers (8 per cent) say they have a poor understanding of university degrees.

LONDON, March 16 /PRNewswire/ -- Millions of people already take a statin to lower their cholesterol and millions more are about to be prescribed these drugs under current guidelines. However, a new book provides substantial evidence to show that most people do not need to lower their cholesterol.

Using official statistics and references from medical literature, the author makes a strong case against the mass prescription of cholesterol-lowering drugs. The key findings in the book are:

LONDON, March 16 /PRNewswire/ --

- New Web-Based Application Empowers Data Stewards and Line of Business Users to Ease Data Management Processes, Streamline MDM Tasks, and Increase Business Adoption for Greater MDM ROI

LONDON, March 16 /PRNewswire/ --

- Ion Thrusters Provide Cruise Control for ESA Gravity Mission to be Launched Today

QinetiQ's (LSE: QQL) electric engines are playing a crucial role on a revolutionary spacecraft to be launched today (Monday) from the Plesetsk cosmodrome in Northern Russia. The electric engines(link: http://www.qinetiq.com/home/defence/defence_solutions/space/ep.html), known as T5 ion thrusters, are providing high-precision drag compensation for the dart-shaped GOCE spacecraft being launched by the European Space Agency (ESA) to map the Earth's gravitational field.

To view the Multimedia News Release, please click:

http://www.prnewswire.com/mnr/qinetiq/37449/

LONDON, March 16 /PRNewswire/ -- SYSTIME http://www.SYSTIME.net, a CMS Group Company and the largest Oracle JD Edwards practice globally, has recently announced commencement of their France operations. This investment is aligned to their strategic decision to expand their European business operations in the ERP space.

SYSTIME's advent in Paris, France along with its European headquarters in London, gives it an expanded network in Europe, allowing proximity to clients and faster response times. Delivering solutions from this near shore facility will also be more convenient and advantageous to clients and will provide customers with seamless service.

LONDON, March 16 /PRNewswire/ --

The need for storing energy along with the preference for cleaner storage techniques opens the door to enormous opportunities for alternative energy storage technologies in numerous end-user and almost all geographical markets worldwide.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

MARSEILLE, France, March 16 /PRNewswire/ --

- WT1 is a Valuable Biomarker in the Prognosis and Follow-up of Acute Myeloid Leukemia (AML) Patients.

- The ProfileQuant(R) WT1 kit was Developed and Validated in the Context of an International Collaborative Study Coordinated by the European Leukemia Network (ELN) Consortium.

- With its WT1 kit, Ipsogen Continues its CE Marking Strategy and Confirms its Leadership Position in Molecular Diagnosis of Leukemia.

IPSOGEN SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, manufacturing and commercialization of diagnostic assays for breast cancer and leukemias, today announces the CE marking of its ProfileQuant(R) WT1 kit.

The climate change skeptic asks - 'Given that the climate changes over millenia due to powerful natural forces, how could humans possibly contribute any significant effect to climate change, given our brief existence in geological time?'

I shall try to answer that question with examples from engineering which show how short-term pulse events can significantly affect long-term cyclic events.

The Influence of Short-Term Events on Long-Term Events.